Allspring Global Investments’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Allspring Global Investments's CDNA Position: Q2 2026 in Review
Allspring Global Investments increased its CareDx (CDNA) stake by 3.8% in Q2 2026, buying an estimated $17.4K and bringing the position to 22,039 shares worth $645K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.
Allspring Global Investments first reported a position in CDNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $12.3M in Q4 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Allspring Global Investments held 22,039 shares of CareDx worth $645K as of Q2 2026.
- Allspring Global Investments bought 797 CareDx shares in Q2 2026, an estimated $17.4K.
- CareDx made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1379 holding.
- Allspring Global Investments first reported a position in CareDx in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's CareDx position peaked at $12.3M in Q4 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.